Research technicians

Jeanelle Tsai, BA, (Jeanellea_tsai@dfci.harvard.edu) is helping to identify genes that cause drug resistance in EGFR-mutant NSCLCs using a genome-wide CRISPR activation screening system. She is assessing the efficacy of targeting those genes in vitro with the goal of eliminating minimal residual disease (MRD).